Cardiovascular Systems, Inc. (CSII) Shares Sold by Millennium Management LLC

Millennium Management LLC lessened its stake in Cardiovascular Systems, Inc. (NASDAQ:CSII) by 78.9% in the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The fund owned 123,986 shares of the medical device company’s stock after selling 462,695 shares during the period. Millennium Management LLC owned about 0.37% of Cardiovascular Systems worth $2,937,000 at the end of the most recent reporting period.

Several other large investors also recently modified their holdings of CSII. Champlain Investment Partners LLC increased its stake in shares of Cardiovascular Systems by 21.3% in the fourth quarter. Champlain Investment Partners LLC now owns 2,253,355 shares of the medical device company’s stock worth $53,382,000 after buying an additional 396,145 shares during the last quarter. Renaissance Technologies LLC increased its stake in shares of Cardiovascular Systems by 69.7% in the fourth quarter. Renaissance Technologies LLC now owns 899,300 shares of the medical device company’s stock worth $21,304,000 after buying an additional 369,500 shares during the last quarter. Brown Capital Management LLC increased its stake in shares of Cardiovascular Systems by 7.0% in the fourth quarter. Brown Capital Management LLC now owns 2,659,509 shares of the medical device company’s stock worth $63,004,000 after buying an additional 173,271 shares during the last quarter. Thomson Horstmann & Bryant Inc. bought a new stake in shares of Cardiovascular Systems in the fourth quarter worth $3,463,000. Finally, BlackRock Inc. increased its stake in shares of Cardiovascular Systems by 4.1% in the fourth quarter. BlackRock Inc. now owns 2,265,706 shares of the medical device company’s stock worth $53,676,000 after buying an additional 88,999 shares during the last quarter. Institutional investors and hedge funds own 82.45% of the company’s stock.

CSII has been the subject of a number of research analyst reports. BidaskClub lowered shares of Cardiovascular Systems from a “sell” rating to a “strong sell” rating in a research note on Wednesday, December 27th. Zacks Investment Research lowered shares of Cardiovascular Systems from a “buy” rating to a “hold” rating in a research note on Monday, February 12th. Leerink Swann dropped their price target on shares of Cardiovascular Systems from $31.00 to $30.00 and set an “outperform” rating for the company in a research note on Thursday, February 8th. Finally, ValuEngine downgraded shares of Cardiovascular Systems from a “hold” rating to a “sell” rating in a report on Friday, February 2nd. Two analysts have rated the stock with a sell rating, six have issued a hold rating and one has given a buy rating to the company’s stock. The stock currently has a consensus rating of “Hold” and an average target price of $27.00.

Cardiovascular Systems stock opened at $22.50 on Tuesday. The firm has a market capitalization of $748.08, a price-to-earnings ratio of 750.00 and a beta of 2.15. The company has a debt-to-equity ratio of 0.17, a current ratio of 4.65 and a quick ratio of 4.13. Cardiovascular Systems, Inc. has a 12 month low of $20.58 and a 12 month high of $33.11.

Cardiovascular Systems (NASDAQ:CSII) last released its quarterly earnings data on Wednesday, February 7th. The medical device company reported ($0.01) EPS for the quarter, topping analysts’ consensus estimates of ($0.04) by $0.03. The firm had revenue of $52.63 million during the quarter, compared to the consensus estimate of $53.39 million. Cardiovascular Systems had a negative net margin of 1.62% and a negative return on equity of 0.50%. The firm’s revenue was up 5.2% on a year-over-year basis. During the same quarter in the previous year, the company posted $0.03 earnings per share. analysts anticipate that Cardiovascular Systems, Inc. will post -0.07 earnings per share for the current fiscal year.

TRADEMARK VIOLATION NOTICE: This piece was reported by WKRB News and is the property of of WKRB News. If you are accessing this piece on another site, it was illegally stolen and reposted in violation of U.S. and international copyright law. The legal version of this piece can be read at https://www.wkrb13.com/2018/04/24/cardiovascular-systems-inc-csii-shares-sold-by-millennium-management-llc.html.

About Cardiovascular Systems

Cardiovascular Systems, Inc, a medical technology company, develops, manufactures, and markets devices to treat vascular diseases in the United States. The company offers peripheral arterial disease products, including Diamondback 360 Peripheral Orbital Atherectomy System (OAS), Diamondback 360 60cm Peripheral OAS, Diamondback 360 4 French 1.25 Peripheral OAS, Diamondback 360 1.50 Peripheral OAS, Diamondback 360 2.00 Peripheral OAS, and Stealth 360 Peripheral OAS, which are catheter-based platforms for treating a range of plaque types in leg arteries above and below the knee, including calcified plaque, as well as address various limitations associated with surgical, catheter, and pharmacological treatment alternatives.

Institutional Ownership by Quarter for Cardiovascular Systems (NASDAQ:CSII)

Receive News & Ratings for Cardiovascular Systems Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cardiovascular Systems and related companies with MarketBeat.com's FREE daily email newsletter.



Leave a Reply